secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILE THERAPEUTICS INC (—)
CIK:        0001261249
Form:       8-K
Filed at:   2024-03-25T23:59:59+00:00
Accession:  0001558370-24-003854
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agile Therapeutics receives final Nasdaq delisting notice; stock to trade on OTC Markets from March 26
--------------------------------------------------------------------------------

- Delisting due to failure to maintain minimum stockholders' equity of $2.5M per Nasdaq Listing Rule 5550(b)(1).
- Trading suspended on Nasdaq at open March 26, 2024; common stock to trade on OTC Markets under symbol AGRX.
- Company does not plan to appeal the Nasdaq Hearings Panel's determination.
- Company expects to continue operations and explore strategic opportunities to maximize Twirla growth.
- Common stock will remain registered under the Exchange Act; company will continue SEC filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1261249/000155837024003854/0001558370-24-003854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1261249/000155837024003854/agrx-20240322x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-003854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer